Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker FRMI
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Nov 5, 2026 | Toby R. Neugebauer 10% owner | FRMI Fermi Inc. | Sale | 5.00M | $1.52 | $7.6M Sale | Form 4 ↗ |
| Nov 4, 2026 | Toby R. Neugebauer 10% owner | FRMI Fermi Inc. | Sale | 94,000 | $1.99 | $187.5K Sale | Form 4 ↗ |
| Nov 3, 2026 | Toby R. Neugebauer 10% owner | FRMI Fermi Inc. | Sale | 1.28M | $2.04 | $2.6M Sale | Form 4 ↗ |
| Nov 3, 2026 | Toby R. Neugebauer 10% owner | FRMI Fermi Inc. | Sale | 1.28M | $2.04 | $2.6M Sale | Form 4 ↗ |
| Oct 20, 2026 | Toby R. Neugebauer 10% owner | FRMI Fermi Inc. | Sale | 420,749 | $3.04 | $1.3M Sale | Form 4 ↗ |
| Jun 30, 2026 | James Richard Perry Director | FRMI Fermi Inc. | Sale | 863,637 | $7.31 | $6.3M Sale | Form 4 ↗ |
| Jun 3, 2026 | Mesut Uzman Chief Nuclear Constr. Officer | FRMI Fermi Inc. | Sale | 79,509 | $6.31 | $501.7K Sale | Form 4 ↗ |
| Jun 3, 2026 | Mesut Uzman Chief Nuclear Constr. Officer | FRMI Fermi Inc. | Sale | 79,032 | $6.31 | $498.7K Sale | Form 4 ↗ |
| Apr 9, 2026 | Charles Lynn Hamilton Chief Site Development Officer | FRMI Fermi Inc. | Sale | 398,140 | $4.58 | $1.8M Sale | Form 4 ↗ |
| Apr 9, 2026 | Blanes Jacobo Ortiz Chief Operating Officer | FRMI Fermi Inc. | Sale | 427,363 | $4.58 | $2.0M Sale | Form 4 ↗ |
| Apr 9, 2026 | Miles E. Everson Chief Financial Officer | FRMI Fermi Inc. | Sale | 427,004 | $4.58 | $2.0M Sale | Form 4 ↗ |
| Apr 8, 2026 | Charles Lynn Hamilton Chief Site Development Officer | FRMI Fermi Inc. | Sale | 375,950 | $4.91 | $1.8M Sale | Form 4 ↗ |
| Apr 8, 2026 | Blanes Jacobo Ortiz Chief Operating Officer | FRMI Fermi Inc. | Sale | 403,545 | $4.91 | $2.0M Sale | Form 4 ↗ |
| Apr 8, 2026 | Miles E. Everson Chief Financial Officer | FRMI Fermi Inc. | Sale | 403,205 | $4.91 | $2.0M Sale | Form 4 ↗ |
| Mar 31, 2026 | Griffin Perry 10% owner | FRMI Fermi Inc. | Sale | 2.00M | $5.54 | $11.1M Sale | Form 4 ↗ |
| Mar 30, 2026 | Griffin Perry 10% owner | FRMI Fermi Inc. | Sale | 9.00M | $5.02 | $45.2M Sale | Form 4 ↗ |
16 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 5:59 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances